Table 4.
Summarized diagnostic value of NBI for OPMD and OSCC within various subgroups.
| Subgroup analysis | Studies | Participants | Sensitivity | Specificity | Diagnostic Odds Ratio | Positive likelihood ratio | Negative likelihood ratio | Area Under Curve |
|---|---|---|---|---|---|---|---|---|
| Subgroup 1 | 9 | 1179 | 0.87 (0.67, 0.96) | 0.83 (0.56, 0.95) | 87.40 (8.62, 886.50) | 7.32 (1.60, 33.47) | 0.08 (0.02, 0.29) | 0.92 (0.89, 0.94) |
| Subgroup 2 | 9 | 1232 | 0.58 (0.19, 0.89) | 0.95 (0.85, 0.99) | 28.38 (7.18, 112.11) | 12.42 (4.72, 32.68) | 0.44 (0.16, 1.18) | 0.94 (0.91, 0.96) |
| Subgroup 3 | 6 | 946 | 0.69 (0.47, 0.85) | 0.97 (0.88, 0.99) | 63.54 (20.17, 200.19) | 20.14 (6.25, 64.85) | 0.32 (0.17, 0.60) | 0.93 (0.90, 0.95) |
| Subgroup 4 | 5 | 890 | 0.97 (0.82, 0.99) | 0.55 (0.23, 0.83) | 36.21 (5.38, 243.74) | 2.14 (1.02, 4.49) | 0.06 (0.01, 0.33) | 0.92 (0.90, 0.94) |
NBI, narrow band imaging; OSCC, oral squamous cell carcinoma; OPMD, oral potentially malignant disorders.